Literature DB >> 26121830

[Analysis the treatment of sudden sensorineural hearing loss with steroid from different administration routes].

Yongtao Qu, Hongyao Chen, Huiping Zhang, Mingli Guo.   

Abstract

OBJECTIVE: To explore the treatment of sudden sensorineural hearing loss with steroid from different administration routes.
METHOD: One hundred and eighty-eight patients with diagnosis of sudden sensorineural hearing loss were selected, in accordance with the random number table, and all patients were divided into three groups. With different administration routes, they were devided into systemic steroid therapy group, intratympanic steroid therapy group and postauricular steroid therapy group,and the curative effects were collected and analyzed. RESULT: The total effective rate was 78.26% in systemic steroid therapy group, 80.70% in intratympanic steroid therapy group and 80.65% in postauricularsteroid therapy group,and no statistical difference was detected among these three groups (P > 0.05).
CONCLUSION: The treatment of sudden sensorineural hearing loss with steroid from different adminsthation routes all can achieve a relatively favorable prognosis, and there were no obvious different among those different treatments.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26121830

Source DB:  PubMed          Journal:  Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi        ISSN: 1001-1781


  2 in total

Review 1.  Intratympanic corticosteroids for sudden sensorineural hearing loss.

Authors:  Stefan K Plontke; Christoph Meisner; Sumit Agrawal; Per Cayé-Thomasen; Kevin Galbraith; Anthony A Mikulec; Lorne Parnes; Yaamini Premakumar; Julia Reiber; Anne Gm Schilder; Arne Liebau
Journal:  Cochrane Database Syst Rev       Date:  2022-07-22

Review 2.  Intratympanic vs systemic use of steroids as first-line treatment for sudden hearing loss: A meta-analysis of randomized, controlled trials.

Authors:  Ting Yang; Hui Liu; Fangyao Chen; An Li; Zhou Wang; Shuangyuan Yang; Shiyu Yang; Wen Zhang
Journal:  J Otol       Date:  2021-02-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.